Professional Documents
Culture Documents
March 29-30, 2021
March 29-30, 2021
Dr. Ocampo/Hizon/Hermogino
14 MORTALITIY 0
DISCHARGE
SERVICE IN PATIENT 703-1
831 MA Invasive Breast CA of NST, Diet: NPO post midnight For MRM, left; SLNB with Dr. A. Valparaiso
62/F left breast IVF: D5NR 1L X 10 hrs once on NPO FS possible ALND,
Meds: Cefazolin 2 gram IV 1 hour prior to OR mastectomy right today
at 8AM
837 EF DM Foot, Left; DMII Diet: LSLF DM Diet MGH today Dr. Teoxon
DTR 91/F HASCVD IVF: PLR 1L x 30cc/ hour
s/p BKA left 3/26/21 Meds: Ampicillin-Sulbactam 750 mg IV Q12, Omeprazole 40 mg IV OD Dr. Orantia/Dr.Quitoy/Dr.Santos
3/22/21 POD 4 Labs:
840 JR Milliary TB, Thoracic Diet DAT (exclude apple and banana) Dr. N. Cruz/ Dr. Castillo
ER 33/M spondylosis IVF: HL
s/p CT guided drainage of Meds: Pregabalin 75mg BID, Dexamethasone 4mg PO TID, Paracetamol 500 mg PO, Omeprazole 40 mg PO, HRZE, Levofloxacin 500mg OD,
1/28/21 paraspinal abscess 3/18/21 Lactulose 30ml ODHS, Dexamethasone 4mg BID
POD6 2/20/21: Crea 0.60/ Na 145/ K 3.98/ eGFR Crea 132.1/ AST 24.0/ Mg 2.10/ ALT 18/
2/20/21: WBC 10.3/ Neutro 82/ Hgb 10.6/ Hct 33.7/ Plt 428
2/22/21: CT of thoracic spine with contrast: Increase in size of lesion behind C7-T3 vertebrae presently measuring 4.2 cm AP x 4cm
width prior size of 2.5cm AP x 2.2 cm width involving the muscles. The lesion extends to the left of T2 vertebra and into the spinal canal
causing spinal canal narrowing at T2-T3. It also causes severe bilateral neural foraminal narrowing, and may affect the bilateral exiting
nerves. Presently, it somewhat extends into subcutaneous space. This lesion causes pathologic fracture of spinous process of T2.
2/25/21: hs-CRP 15.2
¾/21: hs-CRP 7.5
3/6/21: ANA 0.20, Procalcitonin 0.17, Crea 0.50, eGFR-Crea 142.36, ALT 17, AST 24, Wbc 8.9, Neutro 80, Hgb 11.4, Hct 36.1, Plt 360, RBC 3.9
844-1 WN Partial Gut Obstruction Diet: NPO Abdominal Status Dr. Tia
DTR 58/F Secondary to Post Op IVF: PLR 1L x 8 hours Combiflex 1400 kcal x 24 hrs Monitoring
Adhesions s/p APR 2019 Meds: oxycodone + naloxone 10/5 q12 tramadol discontinued, cisplatin and etoposide D3 completed Dr. Orantia/Dr.Quitoy/Dr.Santos
3/22/21 Labs:
845-1 EA Chronic Wound, Back Diet: DM diet 1700 kcal/day no simple sugars Dr. Abesamis
DTR 32/F s/p I&D Debridment Feb IVF: pnss 1k x 125 cc/hr
2021 Meds: D2+1Cefazolin 1 gram IV Q8, D1 Ceftriaxone 2 grams IV Q24 Dr. Orantia/Dr.Quitoy/Dr.Santos
3/28/21` DMII sp debridement,
reconstruction using
fasciocutaneous island
keystone flap
3/29/21 POD 1
802 AS RCC, left, CAP-MR. COVID Diet: DAT w/ SAP Dr. Matias
ER 42/M suspect s/p thoracentesis IVF PLR 1L x 40 cc/hr
3/10/21 3/18/21 Meds: D4 Meropenem 1 g IV Q12, Tramadol 50mg/IV Q8.Metoclropormide 10mgIV q8, Ceftriaxone 2gm IV OD, Azithromycin 500mg pO OD, Dr. A Perez
s/p Radical Nephrectomy Tramadol 50mg IV q6, Pazopanib 200 mg 2 tabs OD (t/s once available) Dr. Ocampo/Quitoy/Hermogino
3/20/21 POD 10 Labs:
s/p 1 unit Prbc 3/11/21 : PT 14.2 vs 13.1/60%act/INR 1.22/PTT 21.8 vs 27.2 AST 22/ALT 15
3/10/21 wbc 8.1/S75/L13/hgb9.3/hct29.8/Platelte188
3/12/2021 Chest CT scan and WAB CT triphasic
Latest hgb 9.8 (9.3) Crea (1.4 (1.7)
815 CB Multiple liver masses t/c Diet full diet Dr. N. Cruz
58/M HCC vs. metastatic form, IVF PNSS 1L X 8 hrs
unkown primary Meds: Vitamin K 10 mg iv q8, Pantoprazole + Domperidone BID Dr. Orantia/Dr.Quitoy/Dr.Santos
Labs:
818 MDC CAP-MR Diet: 1200 kcal in 6 equal feedings 1:1 dilution nutribest Dr. K. Seng E. Roxas / G. Arandia
36/F IVF: pNSS 1ll x 40 cc/hr
Meds: Enoxaparin 0.4 OD, Paracetmaol 300 mg IV Q6, NAC, Piptazo 4.5 gms IV Q8, Plactulose 30 cc ODHS, Levofloxacin 750 mg OD
Labs
735 JET Prostate CA St. IV with bone Diet: LSLF Dr. Diwa
69/M metastasis IVF: pnss 1l x 10 hours
Meds: Levofloxacin 500 mg BID, Tramadol + Paracetamol 37.5/325 mg PO TID RTC
Labs:
715 MJC Choledocholithiasis Diet: NPO For PTC today at 8AM c/o Dr. Sarmiento
41/F s/p ERCP IVF plr 1l x 8 HOURS IR
3/27/21 Meds Dr. Ocampo/Quitoy/Santos
POD 3 Labs
726-2 HS Pleural Effusion, right sec to Diet DAT w SAP To place sinapi drain prior Dr. K. Tan / Dr. Francisco / Dr. Cabasas /
18/M infection s/p CTT insertion IVF: HL to discharge Dr. Albay
2/23/21 s/p streptokinase Meds:
fibrinolysis 3/2/21 Labs:
CCU(0)
IMU(0)
Discharges(14)
936 EA Non-healing wound Left Leg Diet: DM Diet 1,800kcal Physical Rehab Dr. Fojas/ Salvana/ Tiongco/ Cabasa
REF 54/F HASCVD, CAD, IVF: Furosemide 240mg + 216 ML PNSS X 5 MG/HR /Gumasing / S. Tayag
2/27/21 S/P CABG Meds: Ceftriaxone 2 gm IV Q24, spironolactone 25mg, enoxaparin 0.6 ml, ertapenem 1gm, sulodexide 600 csu
DM Type II Labs: 2/27/21 wbc 16.2, N 78, L 15, M 7,E 0, B 0, Hgb 10.7, Hct 33.6, MCV 84.6, MCH 27,MCHC 31.8, Plt ct. 478
s/p wound debridement 3/1/21: Crea 0.60, Na 141, EGFR-CREA: 103.34, K 4, BUN 16.4
3/8/21 3/3/21 crea 0.60, Na 139, eGFR-crea 103.34, bun 17.6, K 3.78; cbc wbc 16.1, N 80, L 13, M 7, RBC 4.1, hgb 10.7, hct 34.2
s/p Aortogram with ¾/21: cbc wbc 17.7 Hgb 12.1 Hct 37.9 plt 254, N 82, L12, M6, Na 140, K 4.03
Peripheral Run off, Iliac Latest hgb 12.1 (10.5) CREA 0.6 k 4.66 Na 140
Artery Stenting 3/12/21
s/p embolectomy with AKA
3/18/21 POD 10
906 VO Covid (+) Diet: DAT For CXR today Dr. Macalino
Moderate Pneumonia IVF: PNSS 1L X 16 hrs
Meds: Remdesivir infusion Dr. Ocampo/Dr. Hizon/Dr. Hermogino
Labs:
920 NL 56/F Covid (+) Diet: mechanically soft diet Dr. Macalino
IVF:
Meds:
Labs:
725-2 RC Tripod fracture, right s/p Diet: DAT MGH Dr. Bernardo/ Dr. Carvajal
ORIF (3/26/21) IVF: PLR 1L X 16 hours
Meds Dr. Ocampo/Quitoy/Santos
Labs
841 PS Massive ascites etiology to Diet DAT w/ SAP mgh Dr. Tia
72/F be determined IVF
Meds: Furosemide 20 mg PO, Ceftazidime 1 gm IV Q8 Dr. Ocampo/Amante/Hermogno
Labs:
3/17/21 WAB UTZ: Massive ascites